Point Mobile포인트모바일
318020 · KOSDAQ · ₩318020 · 포인트모바일
₩2,290▲ ₩15 (0.66%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩28B | ₩18B | ₩30B | ₩28B | ₩17B | ₩13B | ₩23B | ₩21B |
| Cost of sales | ₩16B | ₩10B | ₩19B | ₩16B | ₩10B | ₩6.8B | ₩20B | ₩12B |
| Gross profit | ₩13B | ₩8B | ₩11B | ₩12B | ₩6.8B | ₩5.8B | ₩2.6B | ₩9.1B |
| Operating income | ₩4.2B | ₩372M | ₩2.3B | ₩3.2B | −₩1.3B | −₩1.3B | −₩3.5B | ₩2B |
| Net income | ₩3B | ₩1.6B | −₩677M | ₩5.9B | ₩263M | −₩2.7B | ₩2.3B | ₩1.3B |
| Net income to shareholders | ₩4.6B | ₩1.6B | ₩4.2B | ₩3.8B | −₩2.4B | −₩2.7B | ₩3.5B | −₩697M |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩126B | ₩97B | ₩95B | ₩83B | ₩75B | ₩78B | ₩82B | ₩81B |
| Current assets | ₩77B | ₩68B | ₩65B | ₩52B | ₩44B | ₩47B | ₩51B | ₩50B |
| Cash and equivalents | ₩14B | ₩14B | ₩14B | ₩7.8B | ₩8B | ₩16B | ₩14B | ₩7.6B |
| Total liabilities | ₩67B | ₩44B | ₩43B | ₩36B | ₩32B | ₩31B | ₩32B | ₩36B |
| Current liabilities | ₩58B | ₩35B | ₩20B | ₩15B | ₩14B | ₩13B | ₩16B | ₩19B |
| Borrowings | ₩34B | ₩19B | ₩21B | ₩21B | ₩18B | ₩20B | ₩20B | ₩20B |
| Total equity | ₩59B | ₩53B | ₩52B | ₩47B | ₩43B | ₩47B | ₩50B | ₩44B |
| Shareholders' equity | ₩59B | ₩53B | ₩52B | ₩47B | ₩43B | ₩47B | ₩50B | ₩44B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩20B | ₩7.1B | ₩4.3B | −₩2B | −₩4.1B | ₩1.6B | ₩6B | −₩205M |
| Capital spending | ₩150M | ₩22M | −₩45M | ₩99M | ₩84M | ₩66M | ₩103M | ₩279M |
| Free cash flow | −₩20B | ₩7.1B | ₩4.3B | −₩2.1B | −₩4.2B | ₩1.5B | ₩5.9B | −₩484M |
| Dividends paid | ₩0 | ₩1.2B | — | — | — | — | — | — |
Consolidated where available. Amounts in won.
Also known as: Point Mobile / 포인트모바일 / 318020 / KRX:318020
Source: KRX statistical information